Abbott Laboratories (ABT)
Add to Watchlists Create an Alert
37.48
-0.24 -0.64%
NYSE
May 23, 4:58PM
BATS Real time
Currency in USD
Abbott Laboratories Cash from Financing Quarterly
Abbott Laboratories Historical Cash from Financing Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 2.506B |
| Sept. 30, 2012 | -2.191B |
| June 30, 2012 | 115.37M |
| March 31, 2012 | 286.07M |
| Dec. 31, 2011 | -1.285B |
| Sept. 30, 2011 | -2.668B |
| June 30, 2011 | -1.386B |
| March 31, 2011 | -684.33M |
| Dec. 31, 2010 | -93.31M |
| Sept. 30, 2010 | -687.11M |
| June 30, 2010 | 212.88M |
| March 31, 2010 | -520.20M |
| Dec. 31, 2009 | 503.37M |
| Sept. 30, 2009 | -856.33M |
| June 30, 2009 | -329.62M |
| March 31, 2009 | 1.685B |
| Dec. 31, 2008 | 47.88M |
| Sept. 30, 2008 | -3.365B |
| June 30, 2008 | 57.68M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
About Cash From Financing
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from financing activities. Includes the company's cash inflows and outflows from issuing cash dividends, issuing and selling stock, and adding or changing loans.
Learn More
ABT Cash from Financing Quarterly Benchmarks
| Companies | |
|---|---|
| Johnson & Johnson | -777.00M |
| Pfizer | 434.00M |
| Eli Lilly and Company | -1.730B |
ABT Cash from Financing Quarterly Range, Past 5 Years
| Minimum | -3.365B | Sep 2008 |
| Maximum | 2.506B | Dec 2012 |
| Average | -455.41M |
